168 related articles for article (PubMed ID: 21464731)
1. Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery.
Syriac S; Durie N; Kesterson J; Lele S; Mhawech-Fauceglia P
Int J Gynecol Pathol; 2011 May; 30(3):231-5. PubMed ID: 21464731
[TBL] [Abstract][Full Text] [Related]
2. Recurrent and metastatic female adnexal tumor of probable Wolffian origin: A case report and review of the literature.
Chen Q; Shen Y; Xie C
Medicine (Baltimore); 2021 Apr; 100(13):e25377. PubMed ID: 33787642
[TBL] [Abstract][Full Text] [Related]
3. Female adnexal tumor of probable Wolffian origin.
Gupta AK; Srinivasan R; Nijhawan R
Indian J Pathol Microbiol; 2014; 57(4):620-2. PubMed ID: 25308022
[TBL] [Abstract][Full Text] [Related]
4. Recurrent female adnexal tumor of probable Wolffian origin treated with debulking surgery, imatinib and paclitaxel/carboplatin combination chemotherapy: A case report.
Wakayama A; Matsumoto H; Aoyama H; Saio M; Kumagai A; Ooyama T; Inamine M; Aoki Y
Oncol Lett; 2017 May; 13(5):3403-3408. PubMed ID: 28529572
[TBL] [Abstract][Full Text] [Related]
5. Tumor of the mesosalpinx: case report of a female adnexal tumor of probable Wolffian origin.
Tianmin X; Weiqim C; Mianhua C; Xiaocui L; Hongwen G; Min Y
Eur J Gynaecol Oncol; 2012; 33(2):233-5. PubMed ID: 22611973
[TBL] [Abstract][Full Text] [Related]
6. Female adnexal tumor of probable wolffian origin: morphological, immunohistochemical, and ultrastructural study with c-kit gene analysis.
Harada O; Ota H; Takagi K; Matsuura H; Hidaka E; Nakayama J
Pathol Int; 2006 Feb; 56(2):95-100. PubMed ID: 16445822
[TBL] [Abstract][Full Text] [Related]
7. Male adnexal tumor of probable Wolffian origin: a new entity in males similar to female adnexal tumor of probable Wolffian origin.
Kanaan C; Genestie C; Just PA; Sibony M
Virchows Arch; 2021 Feb; 478(2):355-360. PubMed ID: 32506155
[TBL] [Abstract][Full Text] [Related]
8. Recurrent female adnexal tumor of probably Wolffian origin: A case report.
Qiu T; Teng Y; Tong J; Tao W; Xu L
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):382-384. PubMed ID: 28600055
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of female adnexal tumor of probable Wolffian origin (FATWO) arising from ovary: a case report.
Türkçapar AF; Seçkin B; Güngör T; Sirvan L; Mollamahmutoğlu L
J Turk Ger Gynecol Assoc; 2013; 14(1):56-9. PubMed ID: 24592074
[TBL] [Abstract][Full Text] [Related]
10. Malignant female adnexal tumor of probable Wolffian origin: a case report.
Heller DS; Kadire B; Cracchiolo B
J Reprod Med; 2011; 56(3-4):175-7. PubMed ID: 21542539
[TBL] [Abstract][Full Text] [Related]
11. Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO).
Mirkovic J; Dong F; Sholl LM; Garcia E; Lindeman N; MacConaill L; Crum CP; Nucci MR; McCluggage WG; Howitt BE
Int J Gynecol Pathol; 2019 Nov; 38(6):543-551. PubMed ID: 30134342
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211).
Alberts DS; Liu PY; Wilczynski SP; Jang A; Moon J; Ward JH; Beck JT; Clouser M; Markman M
Int J Gynecol Cancer; 2007; 17(4):784-8. PubMed ID: 17343607
[TBL] [Abstract][Full Text] [Related]
13. [Female adnexal tumor of probable Wolffian origin (Wolffian adenoma)--2 case reports and literature review].
Kinkor Z; Michal M
Ceska Gynekol; 2003 Jul; 68(4):280-3. PubMed ID: 14515653
[TBL] [Abstract][Full Text] [Related]
14. Malignant Female Adnexal Tumor of Probable Wolffian Origin: Case Report and Literature Review.
Hong S; Cui J; Li L; Buscema J; Liggins C; Zheng W
Int J Gynecol Pathol; 2018 Jul; 37(4):331-337. PubMed ID: 28700436
[TBL] [Abstract][Full Text] [Related]
15. A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome.
Zhu J; Yang Y; Zhou L; Jiang M; Hou M
BMC Cancer; 2010 May; 10():199. PubMed ID: 20465813
[TBL] [Abstract][Full Text] [Related]
16. Female adnexal tumor of probable wolffian origin: clinicopathological, immunohistochemical and cytofluorimetric analyses of a 22-year-old virgin. case report.
Balbi GC; Del Piano L; Labriola D; Visconti S; Monteverde A; Passaro M; Monaco R; Cardone A; Rossiello R; Panariello S; Montone L
Eur J Gynaecol Oncol; 2006; 27(3):313-6. PubMed ID: 16800270
[TBL] [Abstract][Full Text] [Related]
17. Granulosa cell tumor of the broad ligament: report of a case with emphasis on the differential diagnosis with female adnexal tumor of probable Wolffian origin.
Czernobilsky B; Lifschitz-Mercer B; Trejo L; Atlas I
Int J Surg Pathol; 2011 Dec; 19(6):783-6. PubMed ID: 20042404
[TBL] [Abstract][Full Text] [Related]
18. Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: case report.
Raspagliesi F; Martinelli F; Grijuela B; Guadalupi V
J Obstet Gynaecol Res; 2011 Dec; 37(12):1864-7. PubMed ID: 21955167
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus.
Huh WK; Sill MW; Darcy KM; Elias KM; Hoffman JS; Boggess JF; Alvarez RD; Long HJ; O'Malley DM; Birrer MJ
Gynecol Oncol; 2010 May; 117(2):248-54. PubMed ID: 20189232
[TBL] [Abstract][Full Text] [Related]
20. Female adnexal tumor of probable Wolffian origin arising from mesosalpinx: A case report and review.
Liu L; Fang Q; Xing Y
J Obstet Gynaecol Res; 2018 Sep; 44(9):1859-1863. PubMed ID: 29974617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
